Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Assembly Biosciences Stock Forecast NASDAQ:ASMB
Price Target and Analyst Ratings
Historical Ratings
| Date | Upside / Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 2022-04-01 | 610.06% | Truist Securities | $15.00 $12.00 | Maintains | Buy |
| 2021-09-13 | 107.1% | HC Wainwright & Co. | $3.50 | Initiates Coverage On | Neutral |
| 2021-09-02 | - | William Blair | - | Downgrades | Outperform Market Perform |
| 2021-05-10 | 314.2% | SVB Leerink | $8.00 $7.00 | Maintains | Market Perform |
| 2021-03-23 | 373.37% | SVB Leerink | $9.00 $8.00 | Downgrades | Outperform Market Perform |
| 2020-11-06 | 491.72% | Jefferies | $10.00 | Downgrades | Buy Hold |
| 2020-10-19 | 3154.44% | Truist Securities | $55.00 | Initiates Coverage On | Buy |
| 2020-07-08 | 2148.52% | SVB Leerink | $36.00 $38.00 | Maintains | Outperform |
| 2019-10-16 | 1083.43% | Mizuho | $20.00 | Initiates Coverage On | Buy |
ASMB Stock Trend
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.
Given the current short-term trend, the stock is expected to fall -2.02% during the next 3 months and, with a 90% probability hold a price between $1.32 and $2.22 at the end of this 3-month period.
WARNING: Trend forecast is still in the development phase and should be used with caution. Some cases might produce unexpected results such as negative prices at the end of the trend.
Data
| Date | Bottom | Mid | Top |
|---|---|---|---|
| 2022-05-27 | $1.34 | $1.81 | $2.27 |
| 2022-05-31 | $1.34 | $1.80 | $2.27 |
| 2022-06-01 | $1.34 | $1.80 | $2.27 |
| 2022-06-02 | $1.34 | $1.80 | $2.27 |
| 2022-06-03 | $1.34 | $1.80 | $2.27 |
| 2022-06-06 | $1.34 | $1.80 | $2.26 |
| 2022-06-07 | $1.34 | $1.80 | $2.26 |
| 2022-06-08 | $1.34 | $1.80 | $2.26 |
| 2022-06-09 | $1.34 | $1.80 | $2.26 |
| 2022-06-10 | $1.33 | $1.80 | $2.26 |
| 2022-06-13 | $1.33 | $1.80 | $2.26 |
| 2022-06-14 | $1.33 | $1.80 | $2.26 |
| 2022-06-15 | $1.33 | $1.80 | $2.26 |
| 2022-06-16 | $1.33 | $1.80 | $2.26 |
| 2022-06-17 | $1.33 | $1.79 | $2.26 |
| 2022-06-21 | $1.33 | $1.79 | $2.26 |
| 2022-06-22 | $1.33 | $1.79 | $2.26 |
| 2022-06-23 | $1.33 | $1.79 | $2.26 |
| 2022-06-24 | $1.33 | $1.79 | $2.25 |
| 2022-06-27 | $1.33 | $1.79 | $2.25 |
| 2022-06-28 | $1.33 | $1.79 | $2.25 |
| 2022-06-29 | $1.33 | $1.79 | $2.25 |
| 2022-06-30 | $1.32 | $1.79 | $2.25 |
| 2022-07-01 | $1.32 | $1.79 | $2.25 |
| 2022-07-05 | $1.32 | $1.79 | $2.25 |
| 2022-07-06 | $1.32 | $1.79 | $2.25 |
| 2022-07-07 | $1.32 | $1.79 | $2.25 |
| 2022-07-08 | $1.32 | $1.78 | $2.25 |
| 2022-07-11 | $1.32 | $1.78 | $2.25 |
| 2022-07-12 | $1.32 | $1.78 | $2.25 |
Assembly Biosciences, Inc., a biotechnology company, develops oral therapeutics for the treatment of hepatitis B virus (HBV) infection and to restore health to a dysbiotic microbiome in the United States. It is involved in developing core protein allosteric modulators that modulate the HBV core protein, a polyfunctional viral protein at various points in the viral lifecycle. The company also develops microbiome program, a platform that includes t... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
